For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...
It’s hard to know how long anxiety disorders will last when you’re in the thick of them. It was during the mid-2000s that my ...
Johnson & Johnson is starting the year off strong with a $14.6 billion acquisition of the biopharma firm Intra-Cellular Therapies — best known for its blockbuster drug Caplyta. The deal was announced ...
Lexapro is used to treat major depressive disorder (depression) in adults and certain children. It’s also used to treat generalized anxiety disorder in adults. An interaction can occur because ...
By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...
Psychedelic drug company Mind Medicine Inc. (MindMed) (NASDAQ: MNMD) published its 2025 Investor Presentation this week with ...
Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement ...
A Vanderbilt team is setting out on a two-year project that aims to make AI chatbots more effective when part of behavioral ...